Weed (BUDZ) Net Equity Issued and Repurchased (2010 - 2022)

Weed's (BUDZ) quarterly Net Equity Issued and Repurchased came in at $10000.0 in Q2 2022, down 94.12% year-on-year from $170000.0 in Q2 2021, and down 66.67% quarter-over-quarter from $30000.0 in Q1 2022.

Weed (BUDZ) Net Equity Issued and Repurchased (2010 - 2022) Analysis & Trends

Weed's Net Equity Issued and Repurchased history runs 8 years deep, the most recent figure standing at $10000.0 for Q2 2022.

  • On a quarterly basis, Net Equity Issued and Repurchased fell 94.12% year-over-year to $10000.0 in Q2 2022; TTM through Dec 2022 was $40000.0, a 92.86% decrease from a year earlier, with the FY2022 full-year figure at $40000.0, down 92.86% from the prior year.
  • Net Equity Issued and Repurchased eased to $10000.0 in Q2 2022 per BUDZ's latest filing, from $30000.0 in the prior quarter.
  • Across five years, Net Equity Issued and Repurchased topped out at $2.0 million in Q4 2018 and bottomed at $10000.0 in Q2 2022.
  • The 5-year median for Net Equity Issued and Repurchased is $100000.0 (2020), against an average of $381847.1.
  • Across the five-year window, Net Equity Issued and Repurchased jumped 1381.37% in 2018 and slumped 96.25% in 2019, its largest moves.
  • Year by year, Net Equity Issued and Repurchased stood at $2.0 million in 2018, then slumped by 96.25% to $74999.0 in 2019, then surged by 33.34% to $100000.0 in 2020, then dropped by 20.0% to $80000.0 in 2021, then slumped by 87.5% to $10000.0 in 2022.
  • Per Business Quant, the three latest BUDZ Net Equity Issued and Repurchased figures stand at $10000.0 (Q2 2022), $30000.0 (Q1 2022), and $80000.0 (Q4 2021).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 500,000.00
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 23.60 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Weed 3.72 Mn 3.72 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2022 10,000.00
Jun 30, 2022 10,000.00
Mar 31, 2022 30,000.00
Mar 31, 2022 30,000.00
Dec 31, 2021 80,000.00
Dec 31, 2021 80,000.00
Sep 30, 2021 100,000.00
Sep 30, 2021 100,000.00
Jun 30, 2021 170,000.00
Jun 30, 2021 170,000.00
Mar 31, 2021 210,000.00
Mar 31, 2021 210,000.00
Dec 31, 2020 100,000.00
Dec 31, 2020 100,000.00
Sep 30, 2020 100,000.00
Sep 30, 2020 100,000.00
Jun 30, 2020 55,000.00
Jun 30, 2020 55,000.00
Mar 31, 2020 40,000.00
Mar 31, 2020 40,000.00